摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

二甲苯麝香 | 81-15-2

中文名称
二甲苯麝香
中文别名
5-叔丁基-2,4,6-三硝基间二甲苯;2,4,6-三硝基-3,3-二甲基-5-叔丁基苯;1-(1,1-二甲基乙基)-3,5-二甲基-2,4,6-三硝基苯;麝香茬;1-三級丁-3,5-二甲-2,4,6-三硝苯;2,4,6-三硝基-1,3-二甲基-5-叔丁基苯
英文名称
musk xylene
英文别名
1-(1,1-dimethylethyl)-3,5-dimethyl-2,4,6-trinitro-benzene;1-tert-butyl-3,5-dimethyl-2,4,6-trinitrobenzene
二甲苯麝香化学式
CAS
81-15-2
化学式
C12H15N3O6
mdl
——
分子量
297.268
InChiKey
XMWRWTSZNLOZFN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    235.4°C
  • 沸点:
    438.78°C (rough estimate)
  • 密度:
    1.3226 (rough estimate)
  • 闪点:
    2 °C
  • 溶解度:
    氯仿(微溶)、乙酸乙酯(微溶)
  • LogP:
    4.369 (est)
  • 物理描述:
    5-tert-Butyl-2,4,6-trinitro-m-xylene is a white to light-colored crystalline solid. It is insoluble in water and denser than water. Hence sinks in water. Contact may irritate skin, eyes, and mucous membranes. May be toxic by ingestion. Used to make other chemicals.
  • 颜色/状态:
    Plates, needles from alcohol
  • 气味:
    Strong musk odor
  • 蒸汽压力:
    2.25X10-7 mm Hg at 25 °C
  • 分解:
    When heated to decomposition it emits toxic fumes of /nitrogen oxides/.
  • 保留指数:
    1811;1813.6;1813.6;1813.6;1843

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    138
  • 氢给体数:
    0
  • 氢受体数:
    6

ADMET

代谢
观察到的的主要代谢物来自于2-硝基团的还原(2-氨基-5-叔丁基-4,6-二硝基苯乙烯;2-氨基-5-叔丁基-1-甲基-3-羟甲基-4,6-二硝基苯;2-氨基-5-叔丁基-4,6-二硝基苯酚)而4-硝基位的还原效果较差(4-氨基-5-叔丁基-2,6-二硝基苯乙烯;4-氨基-5-叔丁基-1-甲基-3-羟甲基-4,6-二硝基苯)。
The main metabolites observed were derived from the reduction of the 2-nitro group (2-amino-5-tert-butyl-4,6-dinitroxylene; 2-amino-5-tert-butyl-1-methyl-3-hydroxymethyl-4,6-dinitrobenzene; 2-amino-5- tert-hydroxybutyl-4,6-dinitroxylene) while reduction at the 4-nitro position proceeded less effectively (4-amino-5-tert-butyl-2,6-dinitroxylene; 4-amino-5-tert-butyl-1-methyl- 3-hydroxymethyl-4,6-dinitrobenzene).
来源:Hazardous Substances Data Bank (HSDB)
代谢
...麝香二甲苯的两个氨基代谢物是p-NH2-麝香二甲苯和o-NH2-麝香二甲苯...
... Two amine metabolites of musk xylene /are/ p-NH2-musk xylene and o-NH2-musk xylene ...
来源:Hazardous Substances Data Bank (HSDB)
代谢
一个代谢物,葡萄糖醛酸苷,可能是羟基甲基麝香二甲苯,占胆汁中放射性活性的50%以上,显然在胃肠系统中被脱苷并进一步代谢至少形成四种色谱上极性更强的化合物。其中一些成分至少部分被重吸收,导致尿液中代谢物形成一个复杂的轮廓。
... One metabolite, a glucuronic acid conjugate, presumably of hydroxymethyl-musk xylene, accounted for /greater then/ 50% of the radioactivity found in bile and was apparently deconjugated and further metabolized in the gastro-intestinal tract to at least four other chromatographically more polar compounds. Some of these components were at least partially reabsorbed giving rise to a complex profile of urinary metabolites.
来源:Hazardous Substances Data Bank (HSDB)
代谢
六只雄性大鼠(Wistar,6周龄)口服200 mg/kg bw的麝香二甲苯,剂量为0.5 mL橄榄油,持续2周(每周5天)。收集尿液和粪便以鉴定代谢物。还分析了四只胆管插管大鼠的胆汁中的代谢物。尽管没有提供关于各种代谢物相对重要性的定量信息,但作者指出了通过所有三种途径排泄的主要排泄产物。在以下文本中,这些代谢物用“[M]”表示。麝香二甲苯本身[M],2-乙酰氨基-5-叔丁基-1-甲基-3-羟甲基-4,6-二硝基苯[M],2-氨基-5-叔丁基-1-甲基-3-羟甲基-4,6-二硝基苯[M]和2-氨基-5-叔丁基-4,6-二硝基-间二甲苯[M]在粪便、胆汁和尿液中被发现。4-氨基-5-叔丁基-4,6-二硝基-间二甲苯和一个未识别的代谢物在粪便和尿液中被发现。2-氨基-5-叔羟基丁基-4,6-二硝基-间二甲苯在胆汁和尿液中被发现,4-氨基-5-叔丁基-1-甲基-3-羟甲基-2,6-二硝基苯在尿液中被发现。另一个代谢物被鉴定为5-叔羟基丁基-1,3-二甲基-2,4,6-三硝基苯或1-甲基-3-羟甲基-5-叔丁基-2,4,6-三硝基苯,它以未指明的结合产物形式在胆汁中排泄。未观察到与其他代谢物的结合。
Six male rats (Wistar, 6 week old) were given oral doses of 200 mg/kg bw of musk xylene in 0.5 mL olive oil for 2 weeks (5 days per week). Urine and faeces were collected for identification of metabolites. Bile from four bile duct cannulated rats ... was also analyzed for metabolites. Quantitative information with respect to relative importance of the various metabolites was not provided, but the authors ... stated which the main excretion products via all three routes were. In the following text these are indicated by "[M]". Musk xylene itself [M], 2-acetylamino-5-tert-butyl-1-methyl-3-hydroxymethyl-4,6- dinitrobenzene [M], 2-amino-5-tert-butyl-1-methyl-3-hydroxymethyl-4,6-dinitrobenzene [M] and 2-Amino-5-tert-butyl-4,6-dinitro-m-xylene [M] were found in feces, bile, and urine. 4- Amino-5-tert-butyl-4,6-dinitro-m-xylene and an unidentified metabolite were found in feces and urine. 2-Amino-5-tert-hydroxybutyl-4,6-dinitro-m-xylene was found in bile and urine and 4- amino-5-tert-butyl-1-methyl-3-hydroxymethyl-2,6-dinitrobenzene was found in urine. Another metabolite was identified as either 5-tert hydroxybutyl-1,3-dimethyl-2,4,6 trinitrobenzene or 1- methyl-3-hydroxymethyl-5-tert-butyl-2,4,6 trinitrobenzene, which was excreted as unspecified conjugation product in the bile. Conjugation with other metabolites was not observed.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 毒性总结
鉴定和使用:麝香二甲苯是一种具有甜味和麝香味的固体。它被大量用于廉价香皂和家用产品中。人类研究:一些患者出现持续性的轻微反应/慢性光化性皮炎(暴露在光线下的瘙痒性皮炎伴有苔藓样变),即使患者移除了暴露源,这种反应也可能持续数年。这种反应的机制尚不清楚。它可引起光变应性接触性皮炎。报告指出,血液中麝香二甲苯水平与化妆品使用频率(尤其是香水)、雄烷二醇葡萄糖苷酸水平和产科病史之间存在显著关联。麝香二甲苯在有无代谢激活的人淋巴细胞中均未诱导姐妹染色单体交换。在体外微核试验中,麝香二甲苯在135和350 uM的剂量下,分别未增加人淋巴细胞和人肝癌细胞系Hep G2的微核频率。动物研究:麝香二甲苯在兔眼中不是刺激物。麝香二甲苯在豚鼠中不产生光变应性。在急性毒性试验中,将麝香二甲苯以125、250、500、1000、2000或4000 mg/kg体重的剂量通过灌胃给予小鼠,观察14天。在给予4000 mg/kg体重雄性和雌性小鼠后3-18小时观察到震颤。三组各50只雄性和50只雌性小鼠在含有0、750或1500 mg/kg的麝香二甲苯的饮食中喂养80周。麝香二甲苯增加了两性的肝腺瘤发生率和雄性的肝细胞癌发生率。在雄性小鼠中,哈德氏腺腺瘤的发生率也有所增加。在发育研究中,麝香二甲苯在60和200 mg/kg体重的大鼠中产生了母体毒性。然而,繁殖和窝参数未受到麝香二甲苯的影响。在200 mg/kg组中观察到额外的胸廓肋骨和舌骨位点以及前爪指骨的骨化增加。麝香二甲苯在4株伤寒沙门氏菌和有无代谢激活的大肠杆菌中进行的诱变性试验均为阴性。麝香二甲苯在一组短期遗传毒性试验中进行了评估,包括小鼠淋巴瘤试验、中国仓鼠卵巢(CHO)细胞的体外细胞遗传学试验、原代大鼠肝细胞中的体外未计划DNA合成(UDS)试验和体内UDS试验。麝香二甲苯在这些遗传毒性试验中均给出了阴性结果。这些观察结果,结合先前报告的阴性Ames试验,表明麝香二甲苯诱导小鼠肝肿瘤的机制是非遗传毒性的。生态毒性研究:在斑马鱼和欧洲鲈鱼胚胎细胞中,即使经过短暂的接触时间,麝香二甲苯也表现出遗传毒性活性。
IDENTIFICATION AND USE: Musk xylene is a solid with sweet, musky odor. It is used in large quantities in inexpensive perfumes for soap and household products. HUMAN STUDIES: Some patients develop a persistent light reaction/chronic actinic dermatitis (pruritic dermatitis with lichenification on the light-exposed areas), which can persist for years, in spite of the patient having removed the exposure. The mechanism behind this reaction is not known. It can cause photoallergic contact dermatitis. Significant associations were reported between musk xylene levels in blood and the frequency of cosmetics use (especially with perfumes), the level of androstanediol-glucuronide, and obstetric history. Musk xylene did not induced sister chromatid exchanges in human lymphocytes with and without metabolic activation. In an in vitro micronucleus test, musk xylene at doses up to 135 and 350 uM did not increase the frequency of micronuclei in human lymphocytes and in the human hepatoma cell line Hep G2, respectively. ANIMAL STUDIES: Musk xylene is not an eye irritant in rabbits. Musk xylene does not produce photoallergy in guinea pigs. In an acute toxicity test musk xylene was given by gavage to mice at doses of 125, 250, 500, 1,000, 2,000, or 4,000 mg musk xylene/kg bw. The mice were observed for 14 days. Tremor was observed 3-18 hours after treatment in males and females given 4,000 mg/kg bw. Three groups of 50 male and 50 female mice received a diet containing musk xylene 0, 750 or 1500 mg/kg for 80 weeks. Musk xylene increased the incidence of liver adenomas in both sexes and of liver carcinomas in males. In male mice, the incidence of Harderian gland adenomas was also increased. In developmental studies musk xylene produced maternal toxicity in rats at 60 and 200 mg/kg bw. However, reproduction and litter parameters were unaffected by musk xylene administration. Extra thoracic ribs and increased ossification of hyoid sites and forepaw phalanges were observed in the 200 mg/kg group. A musk xylene mutagenicity test was negative in 4 strains of Salmonella typhimurium, and in Escherichia coli with or without metabolic activation. Musk xylene was evaluated in a battery of short-term genotoxicity tests that included the mouse lymphoma assay, an in vitro cytogenetics assay in Chinese hamster ovary (CHO) cells, the in vitro unscheduled DNA synthesis (UDS) assay in primary rat hepatocytes and an in vivo UDS assay. Musk xylene gave uniformly negative results in these genotoxicity tests. These observation, combined with previously reported negative Ames tests, suggest a non-genotoxic mechanism for the induction of mouse liver tumors by musk xylene. ECOTOXICITY STUDIES: In teleost Danio rerio and the Dicentrarchus labrax embryonic cells musk xylene exhibited a genotoxic activity even after short exposure times.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌性证据
评估:对于人类而言,缺乏关于麝香二甲苯致癌性的足够证据。在实验动物中,关于麝香二甲苯致癌性的证据有限。麝香二甲苯的致癌性对人不可分类(第3组)。
Evaluation: There is inadequate evidence in humans for the carcinogenicity of musk xylene. There is limited evidence in experimental animals for the carcinogenicity of musk xylene. Musk xylene is not classifiable as to its carcinogenicity to humans (Group 3).
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌物分类
国际癌症研究机构致癌物:麝香二甲苯
IARC Carcinogenic Agent:Musk xylene
来源:International Agency for Research on Cancer (IARC)
毒理性
  • 致癌物分类
国际癌症研究机构(IARC)致癌物分类:第3组:无法归类其对人类致癌性
IARC Carcinogenic Classes:Group 3: Not classifiable as to its carcinogenicity to humans
来源:International Agency for Research on Cancer (IARC)
毒理性
  • 致癌物分类
国际癌症研究机构专著:第65卷:(1996年)印刷工艺和印刷油墨,炭黑及一些硝基化合物
IARC Monographs:Volume 65: (1996) Printing Processes and Printing Inks, Carbon Black and Some Nitro Compounds
来源:International Agency for Research on Cancer (IARC)
吸收、分配和排泄
三只雄性大鼠(威斯达,6周龄)单次口服剂量为70毫克/千克体重的5-叔丁基(3)H麝香二甲苯,用橄榄油给药……大约50%的剂量在24小时内通过尿液和粪便排出,7天内几乎有86%的剂量被回收。通过尿液和粪便的排泄分别约为10.3%和75.5%。7天后,约2%的剂量残留在尸体中。据称,麝香二甲苯的主要排泄途径是通过胆汁进入粪便。然而,没有定量数据可用。脂肪组织和肝脏中的浓度分别为血液水平的3.8倍和2.9倍。肾脏和肺部的水平略高于血液水平。其他组织和器官的水平与血液水平相似或更低。
Three male rats (Wistar, 6 weeks old) were given a single oral dose of 70 mg 5-tert-butyl (3)H musk xylene/kg bw in olive oil ... About 50% of the dose was excreted into urine and feces by 24 hours and almost 86% of the dose was recovered by 7 days. The excretion into urine and feces was about 10.3% and 75.5%, respectively. About 2% of the dose remained in the carcass after 7 days. It is stated that the major route of musk xylene excretion was the feces via the bile. However, no quantitative data were available. Concentrations in adipose tissue and liver were 3.8 and 2.9 times the blood level, respectively. The levels in kidneys and lungs were somewhat higher than the blood level. The other tissues and organs had similar or lower levels than the blood level.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
血液和组织的生物累积通过气相色谱-电子捕获检测器(GC-ECD)在成年和发育中的长埃文斯大鼠中进行测量。雄性和雌性大鼠在交配前10周被喂食含有1、10、33或100毫克/千克饲料的麝香二甲苯。处理在怀孕和哺乳期间继续进行。仔鼠在出生后第1天或第14天被处死。后代表现出剂量依赖性的麝香二甲苯积累,在100毫克/千克饲料的剂量下,雌性大鼠的体内脂肪水平为成年雌性的1/2至3/4,或为成年雄性的3至4倍。牛奶中的麝香二甲苯水平与成年雌性脂肪组织水平相当。在成年期喂食麝香二甲苯的大鼠中,脂肪组织中的水平最高,其他器官(卵巢、肾上腺)也有显著含量。在雌性大鼠中,组织水平比雄性高3.7-6.8倍。这种性别差异无法解释,但根据作者的说法,它与身体脂肪含量无关,也不太可能与消除速率的差异有关。后代中没有这种性别差异。
Bioaccumulation in blood and tissues was measured by GC-ECD in adult and developing Long Evans rats. Males and females were fed a diet containing musk xylene at 1, 10, 33 or 100 mg/kg feed for 10 weeks before mating. Treatment continued during pregnancy and lactation. Pups were killed at postnatal days 1 or 14. Offspring exhibited dose dependent musk xylene accumulation with 1/2 - 3/4 of adult female or 3-4 times adult male body fat levels at 100 mg/kg feed. Musk xylene levels in milk were comparable to adult female adipose tissue levels. In rats fed musk xylene in adulthood, levels were highest in adipose tissue with significant amounts in other organs (ovary, adrenal). In females tissue levels were 3.7-6.8 times higher than in males. This sex difference is not explained, but according to the authors it was unrelated to body fat content and unlikely to be related to differences in rate of elimination. The sex difference was absent in the offspring.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
/MILK/研究人员分析了两种硝基麝香(二甲苯麝香和酮麝香)和五种多环麝香(HHCB、AHTN、ADBI、ATII和AHDI)在瑞典乌普萨拉郡(1996-2003年)初产妇母乳中的含量。研究了麝香浓度可能的时间趋势以及与生活方式/医疗因素(如怀孕期间使用香氛产品)的关联。HHCB显示出最高的中位数浓度(63.9 ng/g脂质),其次是AHTN(10.4 ng/g)和二甲苯麝香(MX)(9.5 ng/g)。其他物质的浓度在大多数情况下低于定量限(2.0-3.0 ng/g)。
/MILK/ Investigators/ analyzed two nitro musks (musk xylene and musk ketone) and five polycyclic musks (HHCB, AHTN, ADBI, ATII, and AHDI) in mother's milk from primiparae women (N = 101) living in Uppsala County, Sweden, 1996-2003. Possible temporal trends in musk concentrations and associations with lifestyle/medical factors, such as use of perfumed products during pregnancy were studied. HHCB showed the highest median concentration (63.9 ng/g lipid) followed by AHTN (10.4 ng/g) and musk xylene (MX) (9.5 ng/g). Concentrations of the other substances were, in most cases, below the quantification limit (2.0-3.0 ng/g).
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
在剃光背部涂抹0.5毫克/千克体重的环-(14)C-麝香二甲苯后,对16只CD Sprague-Dawley大鼠和5只Long-Evans大鼠进行了放射性吸收、分布和排泄的测量……在6小时的应用后,移除敷料,并用含有1%乙醇苯乙醇的棉球擦拭处理过的皮肤区域……在大约6小时内,大约8%的剂量从剃光的背部被吸收。在洗涤后,大约14%的剂量留在皮肤中,继续被吸收。在大约48小时内,大约20%的剂量被吸收,皮肤中剩余2%……在CD大鼠中,120小时后,尿液和粪便中分别排出了平均3.9%和15.2%的剂量,而体内只剩下大约0.2%。在Long-Evans大鼠中,消除速率非常相似,5天内尿液和粪便中分别排出了4.0%和14.0%的剂量。在开始给药后的前48小时内,大部分放射性物质被排出。在48至120小时之间,尿液和粪便中分别排出了少于0.5%和少于3%的剂量。在呼出的空气中没有检测到放射性。在给药后24小时宰杀的动物几乎所有组织中都检测到了放射性。浓度在开始给药后大约8小时最高,然后稳步下降。8小时后最高浓度出现在CD大鼠的胃肠 tract (0.868微克当量/克),脂肪组织(0.159微克/克),肝脏(0.062微克/克),胰腺(0.0425微克/克),肾脏(0.0265微克/克)。在这些组织中的放射性水平在整个研究中保持最高。在肾上腺(8小时后0.0685微克/千克)和甲状腺(0.0696微克/千克)中的放射性浓度也是最高的,直到24小时后迅速下降……在白化病CD大鼠中,眼睛中的放射性浓度在24小时后达到高峰,下降到0.0044微克/千克,在48小时后下降到检测水平以下,而在着色Long-Evans大鼠中,眼睛中的放射性浓度在5天期间逐渐上升,从6小时的0.0041微克/千克上升到120小时后的0.0064微克/千克。在胆管插管的大鼠中,放射性以每小时大约1.4%的剂量稳定地排出,在CD和Long-Evans大鼠中都是如此。胆管插管大鼠24小时内的尿液中的放射性浓度仅为剂量的0.21%,而插管Long-Evans大鼠在48小时内通过尿液排出了总剂量的0.3%,这表明存在肠肝循环。一种代谢物,假设是羟基甲基-麝香二甲苯的葡萄糖醛酸苷,占胆汁中发现的放射性的一半以上,显然在胃肠中解苷并进一步代谢至少四种色谱更极性的化合物。其中一些组分至少部分被重新吸收,导致尿代谢物谱复杂化。
The absorption, distribution and excretion of radioactivity have been measured after topical application of 0.5 mg ring-(14)C-musk xylene/kg bw to the shaven backs of 16 CD Sprague- Dawley and 5 Long-Evans rats ... After a 6 hour application the dressing was removed and the area of treated skin was wiped with cotton wool containing 1% ethanolic phenylethyl alcohol ... About 8% of the applied dose was absorbed from the shaven backs during 6 hours. About 14% of the dose remained in the skin after the washing which continued to be absorbed. A total of about 20% of the dose was absorbed during 48 hours with 2% remaining in the skin ... In CD rats' means of 3.9% and 15.2% of the applied dose had been excreted in the urine and feces, respectively, after 120 hours with only about 0.2% remaining in the carcass. In Long-Evans rats the rate of elimination was very similar with 4.0% and 14.0% of the dose excreted during 5 days in the urine and feces, respectively. Most of the radioactivity was eliminated in the first 48 hours after start of dosing. Between 48 and 120 hours /less than/ 0.5% and /less than/ 3% of the dose was excreted in the urine and feces, respectively. Radioactivity was not detected in expired air. Radioactivity was detected in nearly all the tissues of animals killed after 24 hours. Concentrations were highest at about 8 hours after start of dosing and then declined steadily. Highest concentrations after 8 hours were present in the gastro-intestinal tract (0.868 ug equivalents/g), adipose tissue (0.159 ug/g), liver (0.062 ug/g), and pancreas (0.0425 ug/g), kidneys (0.0265 ug/g) of CD rats. Levels of radioactivity in these tissues remained the highest throughout the study. Concentrations of radioactivity in the adrenals (0.0685 ug/kg after 8 hours) and the thyroid (0.0696 ug/kg) were also among the highest up to 24 hours but then declined rapidly ... In the albino CD rats the concentration of radioactivity in the eyes reached a peak of 0.0044 ug/kg after 24 hours declining to below the level of determination after 48 hours, while in the pigmented Long-Evans rats the concentration of radioactivity in the eyes rose gradually throughout the 5 day period from 0.0041 ug/kg at 6 hr to 0.0064 ug/kg after 120 hours. In the bile duct cannulated rats radioactivity was excreted in the bile at a steady rate of ca. 1.4% of the dose per hour in both CD and Long-Evans rats. The concentrations of radioactivity in the urine of the bile duct cannulated rat was only 0.21% of the dose during 24 hours and the cannulated Long- Evans rat excreted a total of 0.3% of the dose in urine during 48 hours, which suggests an enterohepatic cycle. One metabolite, a glucuronic acid conjugate, presumably of hydroxymethyl-musk xylene, accounted for /greater then/ 50% of the radioactivity found in bile and was apparently deconjugated and further metabolized in the gastro-intestinal tract to at least four other chromatographically more polar compounds. Some of these components were at least partially reabsorbed giving rise to a complex profile of urinary metabolites.
来源:Hazardous Substances Data Bank (HSDB)

安全信息

  • 危险品标志:
    Xn,F,E,N
  • 安全说明:
    S16,S36/37,S46,S60,S61
  • 危险类别码:
    R2
  • WGK Germany:
    2
  • 危险品运输编号:
    2956

SDS

SDS:9cea6ecb887af759e5026c5c398c76e2
查看

制备方法与用途

化学性质

这种物质呈浅黄色粉状或针状结晶,熔点为112.5-114.5℃。它能溶于乙醇(0.9%)、苯甲酸苄酯(25%)、苄醇(9%)及大多数油质香料中。具有干甜的麝香样动物香气,虽然气势较弱但留香时间较长。

用途

这种物质价格低廉,广泛用于低档的各种类型香精中,如日用化学品和廉价化妆品中的香精。它作为定香剂和修饰剂应用广泛,也常用于香皂、香波、香粉香精中。在玫瑰香型中效果尤佳,还可用作松木香型的主要定香剂,在香皂香精中的用量可达3%-6%。

用途

该物质具有强烈的麝香气味,是人造麝香中较低档的品种之一,但由于价格低廉易得,广泛用于化妆品和肥皂香精中作为定香剂。在肥皂中的推荐使用量为0.03-0.15%,去垢剂中为0.003-0.015%,香水则为0.2-0.5%,而在香脂和洗液中的用量为0.01-0.05%。

用途

此外,它还可作为皂用香精、化妆香精的定香剂。根据GB 2760--1996的规定,它是允许使用的香料之一。

生产方法

该物质由氯代叔丁烷与间二甲苯在三氯化铝的存在下反应生成1,3-二甲基-5-叔丁基苯,再用浓硝酸进行硝化后分层、分离,使用碱中和并洗涤,最后通过减压蒸馏获得。

生产方法

另一种生产方法是将氯化叔丁烷在三氯化铝的存在下与间二甲苯反应生成1,3-二甲基-5-叔丁基苯,再用浓硝酸进行硝化而得。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    二甲苯麝香 在 palladium on activated charcoal 氢气 作用下, 以 乙醇 为溶剂, 反应 1.0h, 以90%的产率得到1-tert-butyl-3,5-dimethyl-2,4-diamino-6-nitrobenzene
    参考文献:
    名称:
    Acute aquatic toxicities of four musk xylene derivatives on Daphnia magna
    摘要:
    Musk xylene derivatives were obtained by hydration of the parent compound. These materials were assayed for acute toxicity on Daphnoa magna. In contrast to the parent compound all these reduction products showed acute toxicities below their water solubility. The para-amino-dinitro-musk xylene was highly toxic (EC50 = 0.00025 mg L-1). Ortho- and ortho-para and triamino-musk-xylene were less toxic and showed EC50-values of 1.07, 23.3, 58.8 mg L-1 respectively. A 1:1:1:1 mixture of all derivatives, each in a concentration corresponding to 1/4 of EC50, exhibited a strong concentration-additivity relationship. (C) 1998 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0043-1354(97)00361-8
  • 作为产物:
    描述:
    间二甲苯硫酸硝酸 作用下, 生成 二甲苯麝香
    参考文献:
    名称:
    The Action of Aluminum Chloride on Aromatic Hydrocarbons. I.1 The 1,3-Dimethyl-4-butylbenzenes
    摘要:
    DOI:
    10.1021/ja01870a033
点击查看最新优质反应信息

文献信息

  • A non-acid methodology for polynitration of arenes at low temperatures
    作者:Hitomi Suzuki、Takashi Murashima、Kazuhiro Shimizu、Kenkichi Tsukamoto
    DOI:10.1039/c39910001049
    日期:——
    In the presence of ozone and an appropriate catalyst, nitrogen dioxide acts as a powerful nitrating agent at low temperatures, converting arenes into polynitro derivatives in good yields.
    在臭氧和适当催化剂的存在下,氮氧化物在低温下作为强硝化剂,将芳香烃高效地转化为多硝基衍生物。
  • BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
    申请人:SENOMYX, INC.
    公开号:US20160376263A1
    公开(公告)日:2016-12-29
    The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.
    本发明涵盖已知用于改变苦味感知的化合物和组合物,以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种:冷却剂;无活性药物成分;活性药用成分;食品添加剂或食品;调味剂或调味增强剂;食品或饮料产品;苦味化合物;甜味剂;苦味剂;酸味调味剂;咸味调味剂;鲜味调味剂;植物或动物产品;已知用于宠物护理产品中的化合物;已知用于个人护理产品中的化合物;已知用于家用产品中的化合物;制药制剂;局部制剂;大麻衍生或与大麻相关的产品;已知用于口腔护理产品中的化合物;饮料;香味、香水或除臭剂;已知用于消费品中的化合物;硅化合物;磨料;表面活性剂;发热剂;吸烟物品;脂肪、油脂或乳化剂;和/或益生菌或补充剂。
  • [EN] ESTERS AND ETHERS OF 2,2,4,4-TETRAMETHYLCYCLOBUTANE-1,3-DIOL FOR USE AS AROMA CHEMICALS<br/>[FR] ESTERS ET ÉTHERS DE 2,2,4,4-TÉTRAMÉTHYLCYCLOBUTANE -1,3-DIOL DESTINÉS À ÊTRE UTILISÉS EN TANT QUE PRODUITS CHIMIQUES AROMATIQUES
    申请人:BASF SE
    公开号:WO2019048544A1
    公开(公告)日:2019-03-14
    The present invention relates to the use of a compound of the general formula (I) wherein R1 is C1-C4-alkyl or -(C=0)-R3, R2 is hydrogen, C1-C4-alkyl or -(C=0)-R4, and R3 and R4, independently of one another, are selected from the group consisting of hydrogen and C1-C4-alkyl, a stereoisomer thereof or a mixture of stereoisomers thereof, as an aroma chemical, to aroma chemical compositions comprising at least one compound of the general formula (I), a stereoisomer thereof or a mixture of stereoisomers thereof, and to a method for preparing a fragranced ready-to-use composition, which comprises incorporating at least one compound of the general formula (I), a stereoisomer thereof or a mixture of stereoisomers thereof, into a ready- to-use composition. The present invention further relates to specific ethers and specific esters of the compounds of the general formula (I) and a method for their preparation.
    本发明涉及使用一般式(I)的化合物,其中R1是C1-C4-烷基或-(C=0)-R3,R2是氢、C1-C4-烷基或-(C=0)-R4,R3和R4彼此独立地选自氢和C1-C4-烷基的群,其立体异构体或其立体异构体混合物,作为香料化学品,以及包含至少一种一般式(I)的化合物、其立体异构体或其立体异构体混合物的香料化学品组合物,以及制备香味即用组合物的方法,该方法包括将至少一种一般式(I)的化合物、其立体异构体或其立体异构体混合物纳入即用组合物中。本发明还涉及一般式(I)化合物的特定醚和特定酯以及它们的制备方法。
  • DERIVATIVES OF 1-(4-METHYLCYCLOHEXYL)-ETHANOLS
    申请人:Symrise AG
    公开号:US20170002294A1
    公开(公告)日:2017-01-05
    The invention relates to mixtures having: components (a) having at least one fragrance of the formula (I) where R1=OC-R2, CH 2 OR3, C1-C8 open-chain or branched aliphatic radical, optionally substituted and/or unsaturated, with R2=an open-chain or branched aliphatic radical, optionally substituted and/or unsaturated, having 2-10 C atoms, with R3=an open-chain or branched aliphatic radical, optionally substituted and/or unsaturated, having 1-8 C atoms, and components (b) having at least one fragrance, different from the fragrances of component a, characterized in that the weight ratio of all components (a) to all components (b) is from 1:10 to 1:10000.
    该发明涉及具有以下特征的混合物:组分(a)至少具有一个符合以下式(I)的香料,其中R1=OC-R2,CH2OR3,C1-C8开链或支链脂肪基,可选择地取代和/或不饱和,其中R2=一个开链或支链脂肪基,可选择地取代和/或不饱和,含有2-10个碳原子,其中R3=一个开链或支链脂肪基,可选择地取代和/或不饱和,含有1-8个碳原子,以及组分(b)至少具有一个与组分a的香料不同的香料,其特征在于所有组分(a)与所有组分(b)的重量比为1:10至1:10000。
  • [EN] HIGH-COVERAGE, LOW ODOR MALODOR COUNTERACTANT COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS AGISSANT CONTRE LES MAUVAISES ODEURS, À FAIBLE ODEUR ET À POUVOIR COUVRANT ÉLEVÉ, ET PROCÉDÉS D'UTILISATION
    申请人:INT FLAVORS & FRAGRANCES INC
    公开号:WO2016049523A1
    公开(公告)日:2016-03-31
    The present invention relates to novel compounds and their use as malodor counteractant materials.
    本发明涉及新化合物及其作为恶臭对抗剂材料的用途。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐

相关功能分类